Biomedical science and medical specialties that rely heavily on biophotonics and optics include cell biology, cancer research and oncology, cardiology, neuroscience, dermatology, dentistry, genomics and proteomics, and molecular biology. Applications run the gamut from imaging of all kinds to disease diagnosis, noninvasive monitoring, and light-based therapy.
OCT provides more detail inside carotid arteries
07/31/2012
Researchers at the University of Siena in Italy used optical coherence tomography (OCT) in the carotid arteries of carotid stent patients, thereby gaining more knowledge of cardiac disease and improving the stenting procedure. |
|
Biolase opens corporate technology and training center
07/30/2012
Dental laser manufacturer and distributor Biolase has opened its technology and training center at its corporate headquarters in Irvine, CA. |
|
|
|
Laser-activated resonator and nanostring creates chip-based optomechanical sensor
07/27/2012
Lausanne, Switzerland--EPFL scientists have developed a chip-based optomechanical sensor that they say could revolutionize sensing and atomic force microscopy. |
|
|
Handheld fluorescent probe assists in brain cancer surgery
07/26/2012
The first of its kind to use fluorescence to distinguish cancerous tissue from normal tissue in low-grade brain tumors, researchers have developed a fluorescent probe that could help brain surgeons. |
Pacific Biosciences, Imec to collaborate on single-molecule sequencing solution
07/25/2012
Genome sequencing technology developer and maker Pacific Biosciences (NASDAQ:PACB) and nanoelectronics research center Imec (Leuven, Belgium) will enter into a multi-year research collaboration focused on developing advanced microchips for highly multiplexed, single-molecule genetic analysis. |
|
Femtosecond laser technology destroys cancerous tumors noninvasively
07/24/2012
Researchers at the Center for Laser Applications at the University of Tennessee Space Institute have developed a laser technology that finds, maps, and noninvasively destroys cancerous tumors. |
|
SPIE establishes biophotonics technology development award
07/24/2012
SPIE has established a new award—the Biophotonics Technology Innovator award—which will honor extraordinary achievements in biophotonics technology development that show strong promise or potential impact. |
|
|
|
Microscopy method determines how centromere structure forms
07/20/2012
Scientists at the Stowers Institute of Medical Research have developed a microscopy method—pairing fluorescence correlation spectroscopy (FCS) with calibrated imaging—to count the number of fluorescent molecules in a cluster, and then determine how DNA twists into a unique chromosomal structure called the centromere. |
Laser technique modifies surfaces to prevent the spread of bacteria
07/20/2012
Researchers are applying a laser technique to design nanostructured reliefs on surfaces so that they acquire antibacterial properties and are more resistant to the formation of bacterial biofilms. |
|
Cynosure earns FDA clearance for at-home wrinkle treatment device
07/19/2012
Cynosure (NASDAQ: CYNO) has received FDA clearance to market a home-use, over-the-counter device for treating facial wrinkles. |
|
Global biophotonics market should exceed $99B by 2018, says GIA
07/18/2012
Global Industry Analysts (GIA) recently released a global report on biophotonics markets, forecasting them to exceed $99 billion by the year 2018. |
|
TeraView earns MHRA approval to conduct in-vivo clinical trials for cancer imaging
07/17/2012
Terahertz solutions and technology manufacturer TeraView has received approval by the Medicines and Healthcare products Regulatory Agency (MHRA) to conduct in-vivo clinical trials for cancer research using the company's Terahertz Pulsed Imaging (TPI). |
|
|
|
Super-res microscopy method reveals cause of chronic infections
07/13/2012
Researchers at the University of California, Berkeley, using fluorescent labeling and employing super-resolution microscopy, discovered how many bacterial diseases attack, including cholera, lung infections in cystic fibrosis patients, and chronic sinusitis. |
Carl Zeiss, Olympus enter licensing agreement for digital pathology patents
07/13/2012
Carl Zeiss Microscopy and Olympus America have entered into a nonexclusive worldwide licensing agreement that allows Carl Zeiss to access an extensive portfolio of patents held by Olympus in digital pathology and virtual microscopy. |
|
OCT and microscopy combo enables accurate, noninvasive look at cancerous tumors
07/11/2012
Combining optical coherence tomography (OCT) and confocal microscopy could improve surgeries that remove malignant breast tumors, according to new research at Lehigh University. |
|
|
|
Flow-through optical microscope detects rogue cancer cells
07/11/2012
Knowing that the ability to distinguish and isolate rare cells from a large population of assorted cells is essential for early disease detection and disease monitoring, engineers at the University of California, Los Angeles (UCLA) have developed a new optical microscope that can detect circulating cancer tumor cells, which are precursors to metastasis (the spread of cancer). |
Fractional ablative lasers minimize burn severity
07/06/2012
“…Fractional ablative lasers have become an amazing tool for correcting both the aesthetic and functionality issues presented by serious burn scars,” explains Jill Waibel, MD, medical director at Miami Dermatology and Laser Institute in a presentation at this year’s American Society for Laser Medicine and Surgery (ASLMS) conference. |
|
|
|
ARTIFICIAL RETINAS: PV retinal prosthesis has high pixel density
07/05/2012
Even though age-related macular degeneration and retinitis pigmentosa cause loss of ocular photoreceptors, most of the inner retinal neurons typically survive for a long time. |
|
|
Fiber-optic Cerenkov radiation sensor gets dose for proton cancer therapy
07/03/2012
Researchers at Konkuk University and the National Cancer Center are using the Cerenkov radiation produced in plastic fibers as a signal. |
|
|
Promising for cancer therapy, terawatt laser enables higher energies for particle acceleration
07/02/2012
Physicists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) directed light from the Dresden Laser Acceleration Source (DRACO) perpendicularly and obliquely onto a thin metal foil, allowing them to demonstrate for the first time that accelerated protons follow the direction of the laser light, which could be promising for cancer therapy. |